KRYS
$316.58-4.07%
as of close, Oct 16, 2026
☾ AH $316.58 -4.07%
Krystal Biotech Inc.Stock · HealthcareRussell 2000 0.3%Nasdaq Composite 0.02%US Stock Market 0.01%Russell 3000 0.01%
KRYS financial statements
The full income statement, balance sheet, and cash-flow statement for Krystal Biotech Inc. (KRYS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 28.7M2024-09 28.8M2024-12 28.8M2025-03 28.9M2025-06 28.9M2025-09 29.0M2025-12 29.2M2026-03 29.5M2026-06 29.6M+3.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 389M+33.9% | 291M+473.0% | 50.7M | 0.00 | 0.00 | |
| 228M+1.4% | 225M+40.2% | 160M+10.4% | 145M+112.7% | 68.3M+106.9% | ||
| Research & development | 58.0M+8.3% | 53.6M+15.4% | 46.4M+9.4% | 42.5M+52.3% | 27.9M+55.5% | |
| Selling, general & administrative | 147M+29.1% | 114M+15.6% | 98.3M+26.4% | 77.7M+92.5% | 40.4M+168.1% | |
| General & administrative | — | — | 98.4M+26.6% | 77.7M+92.5% | 40.4M+168.1% | |
| Provision for credit losses | 79.3M+42.8% | 55.5M+642.1% | 7.48M | — | — | |
| Operating income | 161M+145.3% | 65.7M+160.0% | -110M+24.5% | -145M-112.7% | -68.3M-106.9% | |
| Interest expense | — | — | 0.00 | 0.00-100.0% | 1.49M | |
| Pre-tax income | 189M+98.7% | 95.4M+639.4% | 12.9M+109.2% | -140M-101.2% | -69.6M | |
| Income tax | -15.4M-347.9% | 6.20M+215.4% | 1.97M | 0.00 | 0.00 | |
| Net income | 205M+129.7% | 89.2M+715.6% | 10.9M+107.8% | -140M-101.2% | -69.6M-116.3% | |
| $6.84+128.0% | $3.00+669.2% | $0.39+107.1% | -$5.49-75.4% | -$3.13-83.0% | ||
| EPS (basic) | $7.08+126.9% | $3.12+680.0% | $0.40+107.3% | -$5.49-75.4% | -$3.13-83.0% | |
| Weighted-avg shares (basic) | 28.9M+1.2% | 28.6M+5.3% | 27.2M+6.5% | 25.5M+14.8% | 22.2M+18.1% | |
| Weighted-avg shares (diluted) | 30.0M+0.7% | 29.7M+7.2% | 27.8M+8.9% | 25.5M+14.8% | 22.2M+18.1% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.02B+38.1% | 742M+26.2% | 588M+53.2% | 384M-13.2% | 442M+60.8% | ||
| Cash & equivalents | 496M+43.9% | 345M-3.8% | 358M+121.3% | 162M-52.6% | 341M+27.2% | |
| Cash & short-term investments | 828M+38.5% | 598M+12.3% | 532M+40.3% | 379M-13.4% | 438M+61.5% | |
| Accounts receivable | 127M+21.7% | 105M+149.2% | 42.0M | 0.00 | — | |
| Inventory | 40.5M+52.7% | 26.5M+279.5% | 6.99M | 0.00 | — | |
| Prepaid expenses | 14.9M+27.9% | 11.7M+73.8% | 6.71M+45.5% | 4.61M+10.5% | 4.17M+9.9% | |
| 1.33B+26.3% | 1.06B+29.0% | 818M+46.5% | 558M-10.8% | 626M+101.5% | ||
| Property, plant & equipment | 151M-2.8% | 155M-3.7% | 161M-0.3% | 162M+43.9% | 112M+263.9% | |
| Operating lease right-of-use | 7.24M+15.3% | 6.28M-10.6% | 7.03M-12.6% | 8.04M+11.3% | 7.23M+119.2% | |
| Long-term investments | 128M-15.8% | 152M+145.5% | 62.0M+1240.7% | 4.62M-92.8% | 64.4M | |
| Deferred tax assets | 22.8M | 0.00 | — | — | — | |
| Other non-current assets | 287K+24.2% | 231K-12.2% | 263K-18.8% | 324K+337.8% | 74.0K-95.4% | |
| 103M+0.9% | 102M+208.2% | 33.1M+14.7% | 28.8M+12.1% | 25.7M+66.6% | ||
| Accounts payable | 3.24M-35.0% | 4.99M+20.6% | 4.13M+3.8% | 3.98M-52.6% | 8.40M+299.0% | |
| Current lease liability | 1.77M+45.5% | 1.22M-17.4% | 1.47M-5.6% | 1.56M+50.0% | 1.04M-79.6% | |
| Other current liabilities | 3.58M+48.9% | 2.40M+9.3% | 2.20M+723.6% | 267K+206.9% | 87.0K+234.6% | |
| 114M+4.4% | 109M+175.6% | 39.7M+9.6% | 36.2M+10.7% | 32.7M+74.4% | ||
| Non-current lease liability | 7.57M+25.2% | 6.04M-8.7% | 6.62M-10.2% | 7.37M+5.6% | 6.98M+111.1% | |
| Operating lease liability (total) | 9.34M+28.6% | 7.26M-10.3% | 8.09M-9.4% | 8.93M+11.3% | 8.02M+103.3% | |
| Other non-current liabilities | 3.72M+162.4% | 1.42M | 0.00 | — | — | |
| 1.22B+28.9% | 946M+21.5% | 779M+49.1% | 522M-12.0% | 594M+103.2% | ||
| Preferred stock | — | — | — | — | 0.00 | |
| Common stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 1.19B+5.9% | 1.13B+7.6% | 1.05B+30.4% | 804M+9.4% | 735M+102.2% | |
| Retained earnings | 24.2M+113.4% | -181M+33.0% | -270M+3.9% | -281M-99.4% | -141M-97.7% | |
| Accumulated other comprehensive income | 1.14M+697.9% | -190K-129.8% | 638K+187.6% | -728K-346.6% | -163K-2816.7% | |
| Total liabilities & equity | 1.33B+26.3% | 1.06B+29.0% | 818M+46.5% | 558M-10.8% | 626M+101.5% | |
| Common shares issued | 29.2M+1.4% | 28.8M+2.0% | 28.2M+9.6% | 25.8M+2.2% | 25.2M+27.9% | |
| Common shares outstanding | 29.2M+1.4% | 28.8M+2.0% | 28.2M+9.6% | 25.8M+2.2% | 25.2M+27.9% | |
| Shares outstanding (cover) | 29.2M+1.5% | 28.8M+1.8% | 28.3M+9.8% | 25.8M+2.2% | 25.2M+13.6% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 201M+62.7% | 123M+239.0% | -88.8M+11.7% | -101M-109.8% | -47.9M-83.8% | ||
| Depreciation & amortization | 5.72M-4.1% | 5.97M+19.2% | 5.01M+89.4% | 2.64M+42.9% | 1.85M+23.3% | |
| Share-based compensation | 54.5M+11.0% | 49.1M+23.0% | 39.9M+20.2% | 33.2M+116.9% | 15.3M+368.2% | |
| Deferred income taxes | -27.3M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in receivables | 22.1M-64.7% | 62.7M+49.2% | 42.0M | 0.00 | 0.00 | |
| Change in inventory | 6.29M-47.2% | 11.9M+166.1% | 4.47M | 0.00 | 0.00 | |
| Change in payables | 826K-18.3% | 1.01M+1101.0% | -101K+91.9% | -1.25M-276.1% | 712K-9.1% | |
| Other operating activities | 684K+4.9% | 652K+200.5% | 217K+538.2% | 34.0K+107.5% | -454K-4227.3% | |
| -58.4M+64.3% | -163M-297.8% | 82.6M+172.4% | -114M+49.7% | -227M-1928.2% | ||
| Capital expenditure | 12.0M+182.0% | 4.24M-64.1% | 11.8M-77.7% | 53.0M-22.5% | 68.3M+360.4% | |
| Free cash flow | 189M+58.5% | 119M+218.5% | -101M+34.5% | -154M-32.1% | -116M-184.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 435K | 0.00 | 0.00 | — | — | |
| 8.71M-67.8% | 27.0M-86.7% | 203M+473.6% | 35.3M-89.8% | 348M+194.6% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 160M+451.0% | 29.0M-91.8% | 356M+201.3% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 286K+162.4% | -458K-193.6% | -156K-280.5% | -41.0K | 0.00 | |
| Net change in cash | 151M+1224.9% | -13.5M-106.9% | 196M+209.5% | -179M-345.8% | 73.0M-9.6% | |
| Income taxes paid | 14.8M+161.1% | 5.67M | 0.00 | 0.00 | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 7.21B+59.7% | 4.51B+29.0% | 3.50B+71.6% | 2.04B+15.7% | 1.76B+32.4% | |
| P/E | 35.2×-30.5% | 50.6× | — | — | — | |
| P/S | 18.5×+19.2% | 15.5× | — | — | — | |
| P/B | 5.9×+23.9% | 4.8×+3.0% | 4.6×+22.7% | 3.8×+27.0% | 3.0×-34.8% | |
| P/FCF | 38.1×+0.8% | 37.9× | — | — | — | |
| Earnings yield | 2.8%+43.9% | 2.0% | — | — | — | |
| FCF yield | 2.6%-0.7% | 2.6% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: KRYS’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all KRYS filings on SEC EDGAR → Not investment advice.